TY - JOUR
T1 - Progressive loss of creatine maintains a near normal ΔG∼ATP in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gsα
AU - Shen, Weiqun
AU - Vatner, Dorothy E.
AU - Vatner, Stephen F.
AU - Ingwall, Joanne S.
N1 - Funding Information:
This work was supported by grants from the National Institutes of Health : HL059139 , HL033107 , AG014121 , HL069020 , AG027211 , HL069752 , HL093481 , HL095888 and AG023137 to Vatner SF and Vatner DE, and HL 075619 and HL 52320 to Ingwall JS.
PY - 2010/4
Y1 - 2010/4
N2 - Myocardial [ATP] falls in the failing heart. One potential compensatory mechanism for maintaining a near normal free energy of ATP hydrolysis (ΔG∼ATP), despite a fall in [ATP], may be the reduction of myocardial creatine (Cr). To test this, we conducted a longitudinal study using transgenic mice overexpressing cardiac Gsα, which slowly developed cardiomyopathy. Myocardial energetics measured using 31P NMR spectroscopy and isovolumic contractile performance were determined in perfused hearts isolated from 5-, 10-, 17-month-old Gsα and age-matched littermate wild type (WT) mice. In young Gsα hearts, contractile performance was enhanced with near normal cardiac energetics. With age, as contractile performance progressively decreased in Gsα hearts, [ATP] and [PCr] progressively decreased while [Pi] increased only modestly; no changes were observed in WT hearts. Myocardial (but not skeletal) [Cr] in Gsα mice decreased, beginning at an early age (1.5 months). Consequently, cytosolic [ADP] and the free energy available from ATP hydrolysis were maintained at normal levels in Gsα hearts, despite decreased [ATP]. During increased cardiac work caused by supplying isoproterenol, the relationship between the rate pressure product (RPP) and ΔG∼ATP in Gsα mouse hearts demonstrated an increased cost of contraction in failing hearts. Thus, our results suggest that the decrease of myocardial [Cr] and net Pi efflux play compensatory roles by maintaining a nearly normal free energy of ATP hydrolysis in the dysfunctional heart; however, it also increased the cost of contraction, which may contribute to the lower contractile reserve in the failing heart.
AB - Myocardial [ATP] falls in the failing heart. One potential compensatory mechanism for maintaining a near normal free energy of ATP hydrolysis (ΔG∼ATP), despite a fall in [ATP], may be the reduction of myocardial creatine (Cr). To test this, we conducted a longitudinal study using transgenic mice overexpressing cardiac Gsα, which slowly developed cardiomyopathy. Myocardial energetics measured using 31P NMR spectroscopy and isovolumic contractile performance were determined in perfused hearts isolated from 5-, 10-, 17-month-old Gsα and age-matched littermate wild type (WT) mice. In young Gsα hearts, contractile performance was enhanced with near normal cardiac energetics. With age, as contractile performance progressively decreased in Gsα hearts, [ATP] and [PCr] progressively decreased while [Pi] increased only modestly; no changes were observed in WT hearts. Myocardial (but not skeletal) [Cr] in Gsα mice decreased, beginning at an early age (1.5 months). Consequently, cytosolic [ADP] and the free energy available from ATP hydrolysis were maintained at normal levels in Gsα hearts, despite decreased [ATP]. During increased cardiac work caused by supplying isoproterenol, the relationship between the rate pressure product (RPP) and ΔG∼ATP in Gsα mouse hearts demonstrated an increased cost of contraction in failing hearts. Thus, our results suggest that the decrease of myocardial [Cr] and net Pi efflux play compensatory roles by maintaining a nearly normal free energy of ATP hydrolysis in the dysfunctional heart; however, it also increased the cost of contraction, which may contribute to the lower contractile reserve in the failing heart.
KW - Adenosine triphosphate
KW - Cardiomyopathy
KW - Creatine
KW - Gsα transgenic mice
KW - ΔG∼
UR - http://www.scopus.com/inward/record.url?scp=77649274890&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77649274890&partnerID=8YFLogxK
U2 - 10.1016/j.yjmcc.2009.10.029
DO - 10.1016/j.yjmcc.2009.10.029
M3 - Article
C2 - 19913550
AN - SCOPUS:77649274890
SN - 0022-2828
VL - 48
SP - 591
EP - 599
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
IS - 4
ER -